New hope for frail lung cancer patients: immunotherapy combo shows promise
NCT ID NCT04221529
First seen Nov 01, 2025 · Last updated Jun 14, 2026 · Updated 25 times
Summary
This study tested a combination of the immunotherapy drug atezolizumab with standard chemotherapy in 70 patients with advanced small cell lung cancer who were in poor health (ECOG 2). The goal was to see if this treatment is safe and effective for this group, who often have very short survival times. The approach aims to improve overall survival and control the disease, though it is not a cure and ongoing management is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLC, EXTENSIVE STAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asklepios Klinik Altona
Hamburg, 22763, Germany
-
Brüderkrankenhaus St. Josef
Paderborn, 33098, Germany
-
Fachkliniken Wangen
Wangen, 88239, Germany
-
Helios Dr. Horst Schmidt Kliniken Wiesbaden
Wiesbaden, 65199, Germany
-
Helios Universitätsklinikum
Wuppertal, 42283, Germany
-
Johannes Wesling Klinikum
Minden, 32429, Germany
-
Karl Landsteiner Institut für Lungenforschung und Pneumologische Onkologie c/o Wilhelminenspital der Stadt Wien
Vienna, 1160, Austria
-
Klinikum Esslingen GmbH
Esslingen am Neckar, 73730, Germany
-
Klinikum Klagenfurt
Klagenfurt, 9020, Austria
-
Klinikum Löwenstein gGmbH
Löwenstein, 74245, Germany
-
Klinikum der Universität München
München, 80336, Germany
-
Krankenhaus Martha-Maria Halle-Dölau
Halle, 06120, Germany
-
LungenClinic Grosshansdorf GmbH
Großhansdorf, 22927, Germany
-
Niels-Stensen-Kliniken
Georgsmarienhütte, 49124, Germany
-
St. Josef Hospital
Bochum, 44791, Germany
-
Universität Heidelberg
Heidelberg, 69126, Germany
-
Universitätsklinikum Freiburg
Freiburg im Breisgau, 79106, Germany
-
Universitätsklinikum Gießen und Marburg GmbH
Marburg, 35043, Germany
-
Universitätsklinikum Krems
Krems, 3500, Austria
Conditions
Explore the condition pages connected to this study.